Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner

HER2-positive breast cancer (BC) invasiveness and drug-resistance issue is the critical treatment obstacle recently. We investigated the total and phosphorylated status EZH2 expression in database and BC tissue microarray. We demonstrated for the first time that EZH2 is distributed both in cytoplasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Feng, Li, Lili, Zhang, Mengwen, Sun, Shanshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557267/
https://www.ncbi.nlm.nih.gov/pubmed/37803297
http://dx.doi.org/10.1186/s12885-023-11450-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557267/
https://www.ncbi.nlm.nih.gov/pubmed/37803297
http://dx.doi.org/10.1186/s12885-023-11450-9

Ejemplares similares